| Symbol | ENLV |
|---|---|
| Name | ENLIVEX LTD. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 37 DEREH MENACHEM BEGIN ST., TEL AVIV, None None |
| Telephone | 972 (0) 3 7326616 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001596812 |
| Description | None |
New Form EFFECT - Enlivex Ltd. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 9999999995-26-002658 <b>Size:</b> 2 KB
Read moreNew Form SCHEDULE 13G - Enlivex Ltd. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000929638-26-003024 <b>Size:</b> 16 KB
Read moreNASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.
Read moreNASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.
Read moreEnlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion
Read moreEnlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the Worlds Largest Cryptocurrency Exchanges by Spot Trading Volume
Read moreEnlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion
Read moreEnlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
Read moreNASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.
Read more